Literature DB >> 1544467

Cytotoxic action of IL-1 beta against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG-monomethyl-L-arginine.

L Bergmann1, K D Kröncke, C Suschek, H Kolb, V Kolb-Bachofern.   

Abstract

IL-1 beta has been previously shown to act as a cytotoxic agent in islets. Here we show by electron microscopy of alginate encapsulated islets, that islet cell lysis is induced by culturing islets for 24 or 48 h in the presence of IL-1 beta. The extent of lysis depends on the IL-1 beta concentration and is slightly enhanced by the addition of TNF-alpha. Cells can be protected from lysis by NG-monomethyl-L-arginine. Lysis is paralleled by an increase in nitrite concentration in culture supernatants of whole islets but not in supernatants of isolated endocrine cells. The results indicate that IL-1 beta toxicity occurs via inducing in non-endocrine islet cells the synthesis and release of nitric oxide, which has been shown earlier to be highly toxic for islet cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1544467     DOI: 10.1016/0014-5793(92)80110-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

Review 1.  Type 1 (insulin-dependent) diabetes mellitus and nitric oxide.

Authors:  H Kolb; V Kolb-Bachofen
Journal:  Diabetologia       Date:  1992-08       Impact factor: 10.122

2.  Apoptosis and expression of inducible nitric oxide synthase are mutually exclusive in renal mesangial cells.

Authors:  D D Nitsch; N Ghilardi; H Mühl; C Nitsch; B Brüne; J Pfeilschifter
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

3.  Association of nitric oxide production by kidney proximal tubular cells in response to lipopolysaccharide and cytokines with cellular damage.

Authors:  A F Kaboré; M Denis; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.

Authors:  Anne Jörns; Tanja Arndt; Andreas Meyer zu Vilsendorf; Jürgen Klempnauer; Dirk Wedekind; Hans-Jürgen Hedrich; Lorella Marselli; Piero Marchetti; Nagakatsu Harada; Yutaka Nakaya; Gen-Sheng Wang; Fraser W Scott; Conny Gysemans; Chantal Mathieu; Sigurd Lenzen
Journal:  Diabetologia       Date:  2013-12-06       Impact factor: 10.122

5.  Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice.

Authors:  K Hirasawa; H S Jun; K Maeda; Y Kawaguchi; S Itagaki; T Mikami; H S Baek; K Doi; J W Yoon
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines.

Authors:  A Kasuga; T Maruyama; I Takei; A Shimada; T Kasatani; K Watanabe; T Saruta; T Nakaki; S Habu; J Miyazaki
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

Review 7.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12

8.  Nitric oxide is not involved in the initiation of insulin secretion from rat islets of Langerhans.

Authors:  P M Jones; S J Persaud; T Bjaaland; J D Pearson; S L Howell
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

9.  Interleukin-1 beta effects on cyclic GMP and cyclic AMP in cultured rat islets of Langerhans-arginine-dependence and relationship to insulin secretion.

Authors:  I C Green; C A Delaney; J M Cunningham; V Karmiris; C Southern
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

10.  Primary cultures of rat islet capillary endothelial cells. Constitutive and cytokine-inducible macrophagelike nitric oxide synthases are expressed and activities regulated by glucose concentration.

Authors:  C Suschek; K Fehsel; K D Kröncke; A Sommer; V Kolb-Bachofen
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.